What is the first-line treatment, including dosing and duration, for a 13-year-old with severe tinea corporis (ringworm)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Severe Tinea Corporis in a 13-Year-Old

For a 13-year-old with severe tinea corporis, oral terbinafine 250 mg once daily for 1-2 weeks is the first-line treatment, particularly if Trichophyton tonsurans is suspected or confirmed. 1, 2

Treatment Selection and Dosing

Primary Recommendation: Oral Terbinafine

  • Terbinafine 250 mg once daily for 1-2 weeks is the preferred first-line agent for severe tinea corporis in adolescents 1, 2
  • This dosing is particularly effective against Trichophyton tonsurans, the most common causative organism in adolescent wrestlers and athletes (>80% of cases) 1
  • Terbinafine is well-tolerated, effective, and inexpensive, making it the optimal choice 2
  • The 250 mg dose is appropriate for adolescents; higher doses (500 mg) have not shown additional benefit and are not recommended 3

Alternative Option: Itraconazole

  • Itraconazole 100 mg once daily for 15 days is an effective alternative if terbinafine is contraindicated or unavailable 1, 4
  • This regimen achieves an 87% mycological cure rate, superior to griseofulvin (57% cure rate) 1, 4
  • Itraconazole is licensed for children over 12 years in many jurisdictions 4
  • Important caveat: Itraconazole has significant drug interactions with warfarin, certain antihistamines, antipsychotics, midazolam, digoxin, and simvastatin that must be considered 4

Treatment Duration and Monitoring

Duration Considerations

  • Treatment for 1-2 weeks with terbinafine is typically sufficient for tinea corporis 1, 5
  • If using itraconazole, extend treatment to 15 days 1, 4
  • The endpoint should be mycological cure, not just clinical improvement 4

Follow-Up Protocol

  • Repeat mycology sampling is recommended until mycological clearance is documented 4
  • If clinical improvement occurs but mycology remains positive, continue current therapy for an additional 2-4 weeks 6

Organism-Specific Considerations

When Terbinafine is Superior

  • Terbinafine is specifically superior for Trichophyton tonsurans infections, the predominant organism in adolescent tinea corporis gladiatorum 1, 4
  • It also demonstrates excellent efficacy against T. rubrum and T. mentagrophytes 1, 5

When to Consider Itraconazole

  • Itraconazole may be preferred if the causative organism is unknown or if Microsporum species are suspected 4
  • Consider itraconazole if terbinafine fails or is contraindicated 4

Common Pitfalls to Avoid

Do Not Use These Approaches

  • Avoid griseofulvin as first-line treatment - it requires longer treatment duration, is less effective than terbinafine, and has lower cure rates 4
  • Do not use topical therapy alone for severe tinea corporis - oral antifungal therapy is indicated when infection is resistant to topical treatment or extensive 4, 2
  • Avoid combination antifungal-corticosteroid preparations as part of antifungal stewardship to prevent resistance 2
  • Do not increase terbinafine dose to 500 mg - this provides no additional benefit over 250 mg 3

Prevention of Recurrence

Essential Preventive Measures

  • Screen and treat all family members, as over 50% may be affected with anthropophilic species like T. tonsurans 4
  • Clean all fomites (hairbrushes, combs, towels) with disinfectant or 2% sodium hypochlorite solution 4
  • Avoid skin-to-skin contact with infected individuals and do not share towels or personal items 4
  • Cover lesions during the treatment period 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and Management of Tinea Infections.

American family physician, 2025

Guideline

Treatment of Tinea Corporis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Scalp Ringworm (Tinea Capitis) in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.